MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Topic
Melanoma and MAPK Pathways
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

749 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
749 works in the cohort · of 4,299,418page 1 of 15

Labels cover 2 of 749 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 749 of 749 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

affunlabeled
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
Paul B. Chapman, Axel Hauschild, Caroline Robert, John B.A.G. Haanen, Paolo A. Ascierto, James Larkin +22 more
2011· article· en· New England Journal of Medicine· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · noneconsensus · none
7,688
citations
affgemma · no categorygpt · no categorymodels split
Nivolumab in Previously Untreated Melanoma without <i>BRAF</i> Mutation
Caroline Robert, Georgina V. Long, Benjamin Brady, Caroline Dutriaux, Michele Maio, Laurent Mortier +22 more
2014· article· en· New England Journal of Medicine· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · noneconsensus · none
5,352
citations
afffundno abstractunlabeled
ERK signalling: a master regulator of cell behaviour, life and fate
Hugo Lavoie, Jessica K. Gagnon, Marc Therrien
2020· review· en· Nature Reviews Molecular Cell Biology· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · metaepi_narrow+research_integrityconsensus · none
1,202
citations
affno abstractunlabeled
Regulation of RAF protein kinases in ERK signalling
Hugo Lavoie, Marc Therrien
2015· review· en· Nature Reviews Molecular Cell Biology· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · metaepi_narrow+research_integrityconsensus · none
702
citations
affno abstractunlabeled
Cutaneous melanoma
Alexander M.M. Eggermont, Alan Spatz, Caroline Robert
2013· review· en· The Lancet· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · insufficient_payloadconsensus · none
532
citations
affunlabeled
Raf kinase as a target for anticancer therapeutics
Srikala S. Sridhar, David W. Hedley, Lillian L. Siu
2005· review· en· Molecular Cancer Therapeutics· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · metaepi_narrowconsensus · none
247
citations
afffundunlabeled
ERKs in Cancer: Friends or Foes?
Xavier Deschênes‐Simard, Filippos Kottakis, Sylvain Meloche, Gerardo Ferbeyre
2014· review· en· Cancer Research· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · noneconsensus · none
211
citations

How this was built: Screen · Findings · About